President Donald Trump’s health officials want you to take your vitamins. Mehmet Oz, the nominee to lead the Centers for Medicare & Medicaid Services, has fed calves on camera to tout the health wonders of bovine colostrum on behalf of one purveyor in which he has a financial stake. Janette Nesheiwat, the potential surgeon general,…
Try a variety of LLM-based tools yourself. Understand the risks, limitations, and who is working on putting quality frameworks and guardrails in place. Engage your employees and partners in discussions about what might now be possible. The post A CEO’s Guide to AI Exploration: Transforming Organizations and Mindsets appeared first on MedCity News.
In a conversation focused on the technology underlying AI in health care, Chip is joined by Seema Verma, former administrator of the Centers for Medicare & Medicaid Services (CMS), and now Executive Vice President and General Manager at Oracle Health and Life Sciences, the second largest electronic health records (EHR) platform in the U.S. Seema shares her insights on the evolution of EHRs and why it’s necessary to redesign these systems to better…
How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are working with the Trump administration to lower costs? The post Debunked Episode 21: The Drug Price Debate, AI in Healthcare Companies Face Consolidation But How Much? appeared first on MedCity News.
New research from Cedar found that about 40% of collectible healthcare dollars now come from uninsured patients, a share that has jumped 54% in three years. The shift is forcing providers to rethink their revenue cycle strategies as patient payments become more difficult — and more important — to collect. The post The Uninsured Rate…
Check out news from Oral Genome, DataJoint, Health Wildcatters, and more. The post StartUPDATES: New Developments for Healthcare Startups appeared first on MedCity News.
Attovia Therapeutics’ biologic medicines could offer advantages over currently available immune disorder drugs, such as Sanofi’s blockbuster medicine Dupixent. The IPO comes as Attovia looks to expand clinical development of its pipeline in 2027. The post Attovia’s Upsized IPO Brings In $289M to Fund New Kind of Biologic for Immune Disorders appeared first on MedCity…
The initiative aims to foster better medical practice sharing among VA facilities
When control over prescription drug access rests with only a few players, the result is not just market imbalance — it is higher plan costs, increased financial pressures, and ultimately reduced affordability for patients. The post The Path to Fair PBM Competition appeared first on MedCity News.
The World Health Organization has prequalified Coartem Baby, the first and only antimalarial for babies. Novartis developed this combination drug in partnership with Medicines for Malaria Venture. The post Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies appeared first on MedCity News.